8-K ·Filed Apr 23, 2026

CHE

CHEMED CORP
BULLISH
Impact 7/10
Horizonimmediate Processed5mo ago SEC0000019584-26-000010
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised guidance driven by VITAS performance and share repurchases suggests strong underlying momentum; monitor VITAS admissions and Roto-Rooter's marketing costs for future trends.

DirectionBullish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
CHE ▲ +19.71% at T+60d
LONG call ✓ call won +19.71% · α vs SPY +14.63% · entry $421.11 → $504.10
Entry anchored
Apr 23, 03:59 PM ET
via exchange tick
T+1d
+0.38%
call +0.38% · α +0.22%
$422.72
settled 5mo ago
T+5d
+0.92%
call +0.92% · α +0.01%
$424.98
settled 5mo ago
T+20d
+4.85%
call +4.85% · α +0.83%
$441.55
settled 4mo ago
T+60d
+19.71%
call +19.71% · α +14.63%
$504.10
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Chemed reported Q1 2026 earnings with revenue of $657.5M (1.6% YoY growth) and GAAP EPS of $4.84, a slight decrease YoY. Adjusted EPS increased 0.4% to $5.65. VITAS segment revenue grew 3.1% and admissions rose 6.9%, while Roto-Rooter revenue declined 0.9%. The company raised full-year 2026 EPS guidance to $24.00-$24.75, citing strong VITAS performance and share repurchases.

Key Financial Metrics

EPS
$5.65
est $5.63 · +0.4%
Revenue
$657.5M
est $649.8M · +1.2% · +1.6% YoY
Rating
beat

Key Facts

  • Q1 2026 revenue: $657.5M (1.6% YoY growth)
  • Q1 2026 GAAP EPS: $4.84 (0.4% decrease YoY)
  • Q1 2026 Adjusted EPS: $5.65 (0.4% increase YoY)
  • VITAS net revenue: $420.0M (3.1% YoY growth), admissions up 6.9%
  • Roto-Rooter revenue: $237.5M (0.9% decline YoY)
  • Company repurchased 500,000 shares for $197.7M in Q1
  • Full-year 2026 EPS guidance raised to $24.00-$24.75 (from $23.25-$24.25)

Financial Impact

Revenue growth of 1.6% and raised full-year EPS guidance

revenueepsguidance

Risk Factors

  • Roto-Rooter revenue declined 0.9% YoY
  • Roto-Rooter adjusted EBITDA margin declined 218 basis points
  • Elevated marketing costs expected to persist for Roto-Rooter

Market Snapshot

Exchange
NYSE
Sector
Services-Home Health Care Services
Analyst Consensus
50% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000019584-26-000010
Document: che-20260423x8k.htm0000019584-26-000010
Document: 0000019584-26-000010-index-headers.html0000019584-26-000010
Document: 0000019584-26-000010-index.html0000019584-26-000010
Document: 0000019584-26-000010.txt0000019584-26-000010
8-K Data (Synthetic)0000019584-26-000010
10 reports for CHE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CHE — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$541.34 $496.62▼ −8.26%▼ −9.57%$507.50 (−6.25%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$539.72 $515.17▼ −4.55%▼ −3.31%$507.50 (−5.97%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$539.72 $515.17▼ −4.55%▼ −3.31%$507.50 (−5.97%)
Jul 28, 2026
9w ago
Press Release
BULLISH ★ 7/10
$539.36 $548.56▲ +1.71%▼ −3.31%$507.50 (−5.91%)
May 18, 2026
19w ago
Press Release
NEUTRAL ★ 2/10
$441.62 $433.87▼ −1.75%▼ −3.34%$507.50 (+14.92%)
May 1, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$422.16 $422.84▲ +0.16%▼ −5.12%$507.50 (+20.22%)
Apr 23, 2026
23w ago
8-K
BULLISH ★ 7/10
$421.11 $441.55▲ +4.85%▲ +0.83%$507.50 (+20.51%)
Apr 23, 2026
23w ago
Press Release
MIXED ★ 6/10
$421.11 $441.55▲ +4.85%▲ +0.83%$507.50 (+20.51%)
Apr 13, 2026
24w ago
8-K
NEUTRAL ★ 5/10
$387.62 $421.43▲ +8.72%▲ +0.99%$507.50 (+30.93%)
Feb 25, 2026
31w ago
8-K
MIXED ★ 6/10
$396.63 $371.95▼ −6.22%▲ +0.18%$507.50 (+27.95%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (64h 15m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access